Privacy Policy: Research Review will record your email details on a secure database and will not release them to anyone without your prior approval. Research Review and you have the right to inspect, update or delete your details at any time. The views expressed in this Publication are personal to the authors, and do not necessarily represent the views or policy of the Ministry of Health on the issues dealt with in the publication.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.
Research Review publications are intended for New Zealand health professionals.
Perspectives of potentially eligible indigenous Māori on a lung cancer screening programme
Authors: Colhoun SR et al.
Summary: Another Kaupapa Māori qualitative study found support for future lung cancer screening in Aoteoroa New Zealand, and identified key barriers and facilitators of screening. A total of 21 Māori current/ex-smokers and members of their whānau participated in three focus group sessions held in Auckland in August 2019. Being more informed about lung cancer and screening, and enabling healthier future generations, were noted as perceived benefits of screening. Previous negative health service experiences, fear, stigma, and access were noted as barriers. Providers’ cultural competence, clear communication, having a one-stop shop, and support with transport were noted as enablers to screening.
Reference: N Z Med J. 2024;137(1593):45-55.
Abstract
The prevalence and management of atrial fibrillation in New Zealand Māori detected through an abdominal aortic aneurysm screening program
Authors: Sandiford P et al.
Summary: Atrial fibrillation (AF) screening is a feasible, low-cost adjunct to abdominal aortic aneurysm (AAA) screening with potential to reduce ethnic inequities in stroke incidence, according to a study of Māori registered at primary health care practices in Auckland. Among 1933 Māori men (aged 60-74 years) and women (aged 65-74 years) screened for AAA, the prevalence of AF was 7.4%, including 2.4% without a code for AF on their medical record. However, more than half of those without a code had known AF, meaning the true prevalence of newly detected AF was 1.1% (n = 21). Among 19 individuals with newly detected high-risk AF, 10 started appropriate anticoagulation therapy within 6 months. Adverse clinical outcomes were noted in five of the nine individuals who did not commence anticoagulation therapy, including ischaemic stroke in one individual. Among those with previously diagnosed AF, use of anticoagulation therapy rose from 57% before screening to 83% at 6 months after screening. The study authors noted that effective measures are needed to ensure that newly diagnosed high-risk AF is managed according to best practice guidelines.
Reference: Heart Lung Circ. 2024;33(3):304-309.
Abstract